AMGN vs BMEA · P/E 24, rev $36.75B vs $94.7M cap
Amgen Inc (AMGN) versus Biomea Fusion Inc (BMEA) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Biomea Fusion Inc (BMEA) is a biotechnology company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
BMEA does not have a complete income-statement cache yet.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. BMEA currently screens at market cap $94.7M.
Not investment advice. Open the AMGN and BMEA stock pages for the full models.
Not investment advice.